39891-09-3

  • Product Name:6-Chloro-3-Pyridylacetonitrile
  • Molecular Formula:C7H5ClN2
  • Purity:99%
  • Molecular Weight:152.583
Inquiry

Product Details

pd_meltingpoint:49-54 °C

Purity:99%

Buy Good Quality 6-Chloro-3-Pyridylacetonitrile 39891-09-3 with a minimum purity of 99%

  • Molecular Formula:C7H5ClN2
  • Molecular Weight:152.583
  • Vapor Pressure:0.00166mmHg at 25°C 
  • Melting Point:49-54 °C 
  • Refractive Index:1.553 
  • Boiling Point:294.1 °C at 760 mmHg 
  • PKA:-1.02±0.10(Predicted) 
  • Flash Point:131.7 °C 
  • PSA:36.68000 
  • Density:1.262 g/cm3 
  • LogP:1.80108 

2-Chloro-5-pyridineacetonitrile(Cas 39891-09-3) Usage

InChI:InChI=1/C7H5ClN2/c8-7-2-1-6(3-4-9)5-10-7/h1-2,5H,3H2

Company Profile

Bailong Pharmaceutical officially began operations in 2017, located in the High-tech Zone of Jinan City. It is a high-tech enterprise specializing in the research and production of chemical raw materials and advanced pharmaceutical intermediates, and has currently passed the GB/T 19001-2016/ISO 9001 quality management system certification standards. The company is dedicated to serving major pharmaceutical companies, fine chemical production units, large pharmaceutical research and development centers, and other users of pharmaceutical chemicals both domestically and internationally. It has established cooperation with nearly all of the top ten pharmaceutical companies in the country and hundreds of small and medium-sized biotechnology companies, providing specialized services such as the supply of commercial chemicals, technical research and development, production technology outsourcing, and customized chemicals. In 2020, it was included in the list of "Top Ten Suppliers of the Year" for certain A-share listed companies, reaching a long-term cooperation intention to help clients improve production capacity and development efficiency, and push the project to market at full speed.

 

Development History

  • 2020yearThe application for Shandong high-end pharmaceutical intermediates production base was successful, and it was officially put into operation in June 2022
  • 2021yearIn the first quarter, the growth rate reached a new high, with a year-on-year increase of 210%, achieving leapfrog growth in the new fiscal year
  • 2022yearIn December,the independent R&D laboratory building of Yinfeng Bio-City was put into operation to help product R&D and innovation.

39891-09-3 Relevant articles

Synthesis and biological evaluation of N-difluoromethyl-1,2-dihydropyrid-2-one acetic acid regioisomers: Dual Inhibitors of cyclooxygenases and 5-lipoxygenase

Yu, Gang,Praveen Rao,Chowdhury, Morshed A.,Abdellatif, Khaled R.A.,Dong, Ying,Das, Dipankar,Velázquez, Carlos A.,Suresh, Mavanur R.,Knaus, Edward E.

, p. 2168 - 2173 (2010)

A new group of acetic acid (7a-c, R1 = H...

Rapid and Simple Access to α-(Hetero)arylacetonitriles from Gem-Difluoroalkenes

Hu, Dandan,Liu, Jiayue,Ren, Hongjun,Song, Jinyu,Zhang, Jun-Qi,Zhu, Guorong

, p. 786 - 790 (2022/01/28)

A scalable cyanation of gem-difluoroalke...

High-selectivity herbicide N-substitutive alkyl aryloxy phenoxyl propanamide compound and preparation and application thereof

-

Paragraph 0079; 0080; 0081, (2016/10/17)

The invention discloses novel N-substitu...

Design, synthesis, and characterization of α-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolase

Otrubova, Katerina,Cravatt, Benjamin F.,Boger, Dale L.

, p. 1079 - 1089 (2014/03/21)

A series of α-ketooxazoles incorporating...

Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues

Otrubova, Katerina,Brown, Monica,McCormick, Michael S.,Han, Gye W.,O'Neal, Scott T.,Cravatt, Benjamin F.,Stevens, Raymond C.,Lichtman, Aron H.,Boger, Dale L.

, p. 6289 - 6299 (2013/06/26)

The design and characterization of α-ket...

39891-09-3 Process route

3-(cyanomethyl)pyridine 1-oxide
6635-88-7

3-(cyanomethyl)pyridine 1-oxide

(6-chloro-pyridin-3-yl)-acetonitrile
39891-09-3

(6-chloro-pyridin-3-yl)-acetonitrile

2-(2-chloropyridin-3-yl)acetonitrile
101012-32-2

2-(2-chloropyridin-3-yl)acetonitrile

4-chloro-3-cyanomethylpyridine
142892-30-6

4-chloro-3-cyanomethylpyridine

Conditions
Conditions Yield
With trichlorophosphate; for 3h; Heating;
37%
5%
21%
3-(cyanomethyl)pyridine 1-oxide
6635-88-7

3-(cyanomethyl)pyridine 1-oxide

trichlorophosphate
10025-87-3,12599-09-6,63736-95-8,39380-77-3

trichlorophosphate

(5-hydroxy-[3]pyridyl)-acetonitrile
99310-62-0

(5-hydroxy-[3]pyridyl)-acetonitrile

(6-chloro-pyridin-3-yl)-acetonitrile
39891-09-3

(6-chloro-pyridin-3-yl)-acetonitrile

2-(2-chloropyridin-3-yl)acetonitrile
101012-32-2

2-(2-chloropyridin-3-yl)acetonitrile

Conditions
Conditions Yield
 
 

39891-09-3 Upstream products

  • 6635-88-7
    6635-88-7

    3-(cyanomethyl)pyridine 1-oxide

  • 10025-87-3
    10025-87-3

    trichlorophosphate

  • 70258-18-3
    70258-18-3

    2-chloro-5-(chloromethyl)pyridine

  • 143-33-9
    143-33-9

    sodium cyanide

39891-09-3 Downstream products

  • 39891-13-9
    39891-13-9

    2-(6-chloropyridin-3-yl)acetic acid

  • 854267-90-6
    854267-90-6

    1-(6-chloropyridin-3-yl)cyclopropanecarboxylic acid

  • 197376-47-9
    197376-47-9

    ethyl (6-chloro-pyridin-3-yl)acetate

  • 691872-18-1
    691872-18-1

    tert-butyl (2-(6-chloropyridin-3-yl)ethyl)carbamate

Relevant Products